Patients ready for dual-action therapy can choose Compounded Tirzepatide Injection at $289/mo (or $249/mo on the 6-month plan) or Oral Tirzepatide at $349/mo (or $279/mo on the 6-month plan)
Studies on HUA-induced cardiac remodeling have determined that sUA prompts cardiomyocytes to manufacture CXCL1 and CXCR2, which induce macrophage migration
4 GIP plays an important role in the incretin effect in healthy people
Key findings include: Mean weight loss of 24.2% (approximately 58 pounds or 26.2 kg) with 12 mg weekly dose after 48 weeks Dose-dependent efficacy across 1 mg, 4 mg, 8 mg, and 12 mg dose groups At 48 weeks, 100% of participants receiving 8 mg or 12 mg achieved at least 5% weight loss 93% of participants on 12 mg achieved 15% or more weight loss , far exceeding current therapeutic benchmarks Greater weight reduction observed in participants with BMI greater than or equal to 35 compared to those with BMI below 35 The magnitude of weight loss approaches that typically observed only with bariatric-metabolic surgery, representing a potential paradigm shift in pharmacological obesity treatment[11]
See "What is the most important information I should know about Janumet?" Common side effects when taking Janumet include: stuffy or runny nose and sore throat upper respiratory infection diarrhea nausea and vomiting gas, stomach discomfort, indigestion weakness headache Taking Janumet with meals can help reduce the common stomach side effects of metformin that usually occur at the beginning of treatment
